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A B ST R AC T 
 
 
Backgrounds. Alexithymia is a relevant phenomenon, occurring transversally 
to healthy subjects and individuals affected by several conditions. Its role is 
considerable, according to current state of the art several conditions emerged 
as influenced, maintained and worsened by alexithymic structures and figures. 
The present study was aimed at highlighting the existing relations, the 
differences and the directions assumed by alexithymic factors and health status 
in patients affected by psychosomatic conditions. Methods. The sample 
consisted of 150 participants, 42 males (28.0%) and 108 females (72.0%), aged 
26 to 78 years old with a mean of 42.24 years old (SD = 12.39). Subjects were 
previously assessed through DCPR-SI, in order to identify psychosomatic 
issues. The study evaluated measures related to alexithymia (Tas-20) and 
health status (SF-36), and considered demographic characteristics such as age, 
gender, and education. Results and Conclusions. The analyses demonstrated a 
number of significant relationships between alexithymia, psychological 
outcomes, and physical outcomes, including psychosomatic disorders. In 
addition, sex differences were found in gastrointestinal outcomes, as well as 
outcomes related to energy/fatigue and physical functioning. The study of 
alexithymia may provide a fruitful approach in understanding various issues 
related to pathology and general health. Further studies are needed to expand 
the understanding of alexithymia to other groups and health-related outcomes.   
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“Alexithymia” describes a condition characterized by 
marked difficulty in indicating, describing, and being 
aware of emotions, the reduction of imagination, and a 
marked concern with concrete and detailed aspects of the 
external environment [1,2]. Theoretical and clinical 
interest in alexithymia has grown over the past decades, 
producing new perspectives while also revealing the need 
to improve constructs and refine clinical practice and 
useful psycho-diagnostics tools [3-5].  
Alexithymia has a number of physical consequences 
[6-8], and it is associated with psychological 
characteristics that may have a direct role in the onset of 
various disorders and medical conditions [9-16]. These 
physical disorders include [17], but are not limited to, 
dermatological [18], cardiovascular [19,20] and 
gastrointestinal functional/structural issues [21-23]. Given 
that psychosomatic research has associated dermatological 
issues with psychological factors, it is not surprising that 
alexithymia may play a role [24-28]. A similar process may 
well be described for gastrointestinal, eating, and 
cardiovascular disorders [29-35]. In addition, the role of 
alexithymia in understanding a number of chronic 
conditions may be facilitated by understanding its 
relationship to specific psychological factors such as 
externally oriented thinking/operative thinking) and 
structures (psychosomatic order), suggesting a possible 
mediating role for such factors in chronic and worsening 
health conditions [36-38]. As such, alexithymia may play 
an increasingly important role in clinical practice [39-41]. 
Given the above, further study is needed to understand 
the role of alexithymia in different populations and for 
other psychological and physical/medical outcomes. In the 
present study, we assessed the relationship of alexithymia 
with a number of physical and psychological outcomes, 
Liam Alexander MacKenzie Myles et al. 
 87 
including physical functioning, energy, fatigue, emotional 
well-being and general health status in subjects reporting 
psychosomatic outcomes.   
Study hypotheses 
To address the above goal, we carried out research that 
addressed three hypotheses. (1) demographic 
characteristics such as age and gender will be associated 
with alexithymia and health status. (2) various factors 
related to alexithymia will be associated with health status 
and psychosomatic outcomes. And (3) Differences will 
occur between male and female participants regarding 
health status and physical outcomes. 
Materials and Methods 
Participants 
The sample consisted of 150 participants, 42 males 
(28.0%), and 108 females (72.0%), aged 26 to 78 years old 
with a mean of 42.24 years (SD = 12.39). Each participant 
completed the protocol, including providing information 
about education, gender, and age. Each participant, before 
providing informed consent, was informed about the 
anonymous nature of data collection process, consistent 
with the 1964 Declaration of Helsinki. 
Instruments and procedure 
Subjects were selected on the basis of their 
psychosomatic conditions, as evaluated by the Diagnostic 
Criteria for Psychosomatic Research Structured Interview-
DCPR-SI [42,43], a structured interview containing a set 
of 12 syndromes of disease phobia, thanatophobia, health 
anxiety, illness denial, persistent somatization, functional 
somatic symptoms secondary to a psychiatric disorder, 
conversion symptoms, anniversary reaction, irritable 
mood, type A behaviour, demoralization, and alexithymia. 
According to Galeazzi et al. [44], the DCPR-SI indexes has 
high interrater reliability with kappa values of: Disease 
phobia, 0.97; Thanatophobia, 0.92; Type A behaviour, 
0.92; Illness denial, 0.90; Demoralization, 0.90; 
Anniversary reaction, 0.90; Health anxiety, 0.89; 
Alexithymia, 0.89; Conversion symptoms, 0.82, Persistent 
somatization, 0.70; and Irritable mood, 0.69. 
Psychosomatic outcomes were considered on the basis of 
three main groups (assessed through a 10-point Likert 
scale, [17], as suggested by Picardi et al. (dermatological) 
[18], (cardiovascular) [19,20], (gastrointestinal) [21-23].  
The Short Form Health Survey (SF-36) [45], Italian 
version by Apolone & Mosconi, 1998; Hays & Sherbourne, 
[46,47] regarding RAND Medical Outcomes Study, 
maintaining the same items) was used to study specific 
health dimensions: physical functioning, energy/fatigue, 
emotional well-being, general health. According to the 
validation study (adhering to RAND structure and factors), 
the various factors yielded the following alphas: physical 
functioning, 0.93, energy/fatigue, 0.86, emotional well-
being, 0.90, general health, 0.78.  
Toronto Alexithymia Scale [48] is a self-report 
instrument consisting of 20 items structured on a 5-points 
Likert scale. TAS-20 has demonstrated an internal 
consistency of 0.81 (Cronbach’s alphas), reporting a three 
factors structure (31% of the total variance), in particular 
Difficulty in Identifying Feelings (0.78), Difficulty in 
Describing Feelings (0.75), and Externally Oriented 
Thinking (0.66). Bressi et al. [49] published a cross 
validation of the Tas-20, including both clinical and non-
clinical subjects. Alpha coefficient scores obtained with the 
non-clinic sample were 0.75 (full scale), and 0.77, 0.67 and 
0.52 for the three factors; the clinical sample scores were 
0.82 (full scale), and 0.79, 0.68 and 0.54 for the three 
factors. Subsequent research highlighted the good 
consistency and reliability of the three factors structure 
[50,51].  
Statistical analysis 
Numerical data were expressed as means and standard 
deviations, categorical variables as number and 
percentage. The Spearman test was used to evaluate 
correlations among alexithymia, health and psychosomatic 
variables of the following instruments. Student’s t-test 
compared gender groups, referring to health status and 
psychosomatic outcomes. A P-value smaller than 0.050 
was considered to be statistically significant. All analyses 
were performed using SPSS 26.0 for Window package.  
Results 





Years of study 15.79 3.11 
Tas-20 Total score 50.43 12.46 
Difficulty in Identifying Feelings  15.45 6.55 
Difficulty in Describing Feelings 13.24 3.84 
Externally Oriented Thinking 25.32 4.88 
Physical functioning 17.32 3.76 
Energy/fatigue 9.06 3.64 
Emotional well-being 12.98 4.51 
General health 11.92 3.54 
Dermatological outcomes 17.32 9.32 
Gastrointestinal outcomes 20.72 8.39 
Cardiovascular outcomes 17.00 7.70 
    
Alexithymia and physical outcomes in psychosomatic subjects 
 88 
 
Table 2. Spearman correlation coefficients among Hp-
1 variables 
                                                                  Age 
Years of 
education 
Tas-20 Total score .170* -.165* 
Difficulty in Identifying Feelings  .151 -.149 
Difficulty in Describing Feelings .104 -.124 
Externally Oriented Thinking .200* -.117 
Physical functioning -.375** .311** 
Energy/fatigue .073 -.275** 
Emotional well-being .101 -.129 
General health -.173* .050 
*p < 0.05 (two-tailed). **p < 0.01 (two-tailed). Bold 
values were the significant values. 
 
Hypothesis 1 
As noted in Table 2, age and education showed 
significant correlations with several assessment scores. 
Regarding age, significant and positive correlations 
emerged with Tas-20 total score, externally oriented 
thinking, and general health status. A negative and 
significant relation emerged with physical functioning. 
Regarding years of study, negative and significant relations 
emerged among years of study, Tas-20 total score, and 
energy-fatigue. The only positive correlation emerged was 
referred to physical functioning. 
Hypothesis 2 
Hypothesis 2 was concerned with relationships among 
alexithymia (including related factors), health status, and 
psychosomatic outcomes. Results demonstrated significant 
positive relations with the onset of psychosomatic issues 
and negative significant correlations with health status 
(Table 3).  
 












Physical functioning -.326** -.352** -.269** -.156 
Energy/fatigue -.190* -.181* -.206* .004 
Emotional well-being -.320** -.398** -.177* -.077 
General health -.328** -.397** -.205* -.121 
Dermatological outcomes .106 .242** .057 -.059 
Gastrointestinal outcomes .253** .210** .220** .235** 
Cardiovascular outcomes .331** .299** .223** .251** 
*p < 0.05 (two-tailed). **p < 0.01 (two-tailed). Bold values were the significant values. 
Regarding the Toronto Alexithymia Scale, significant 
negative correlations were found with physical 
functioning, energy/fatigue, emotional well-being, and 
general health status. Moreover, significant positive 
relationships emerged with gastrointestinal and 
cardiovascular outcomes. With regard to difficulty in 
identifying and describing feelings, significant negative 
correlations occurred with physical functioning, 
energy/fatigue, emotional well-being, and general health. 
Significant positive correlations emerged with 
dermatological, gastrointestinal, and cardiovascular 
outcomes, but no significant correlation was found 
between difficulty in describing feelings and 
dermatological outcomes. Externally oriented thinking was 
significantly and positively related to gastrointestinal and 
cardiovascular outcomes. In general, results concerning 
this second hypothesis highlighted relationships between 
alexithymia, negative health status, and increased 
psychosomatic issues.  
 
Table 4. Comparison between male and female groups 
    Variables Male Female p-value 
Dermatological 16.38±9.42 17.68±9.29 ,447 
Gastrointestinal 18.26±7.85 21.68±8.44 ,021* 
Cardiovascular 15.85±7.53 17.45±7.75 ,251 
Physical 
functioning 
18.42±2.30 16.88±412 ,005* 
Energy/fatigue 10.14±4.00 8.64±3.41 ,037* 
Emotional well-
being 
14.04±5.41 12.57±4.06 ,115 
General health 11.92±3.47 11.92±3.59 ,997 
*p < 0.05; Bold values were the significant values. 
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Hypothesis 3 
Hypotheses 3 was concerned with potential sex 
differences on a series of outcome variables (Table 4). 
Significant differences emerged on gastrointestinal 
outcomes, with higher scores in women, and on physical 
functioning and energy/fatigue, with higher scores in men. 
Discussions 
The current study examined relationships between 
alexithymia and health status using validated psycho-
diagnostics tools, with results indicating a number of 
significant findings. In the first set of analyses, we 
considered the role of the demographic factors of age and 
education. Both variables were related to alexithymic total 
scores, as well as other specific physical and psychological 
outcomes, similar to a number of other studies [52-57]. In 
this respect, the first hypothesis was supported by our 
findings and also consistent with previously reported 
studies.  
Regarding the second hypothesis, several significant 
findings emerged regarding the alexithymic domains and 
health status. As might be expected, physical, 
psychological, and general health were negatively related 
to higher alexithymic symptoms. In contrast, higher 
alexithymic scores were related to increased 
psychosomatic outcomes, including dermatological, 
cardiovascular, and gastrointestinal.   
Regarding dermatological outcomes, the results 
suggested the strong link with the first alexithymic factor, 
that is, difficulty in identifying feelings. Such a link has 
been previously documented by research on 
psychosomatics and dermatological issues, as in the case 
of psoriasis, vitiligo, and other relevant illnesses [58-61]. 
Gastrointestinal and cardiovascular outcomes were even 
more strongly related to alexithymia, relationships also 
strongly reported in the literature [23, 62-66]. 
The third hypothesis was concerned with differences in 
physical outcomes and health status between men and 
women. Some significant differences emerged, with higher 
scores in men on physical functioning and energy/fatigue, 
and higher scores in women on gastrointestinal disorders. 
These findings are consistent with other recent studies 
showing relationships between gastrointestinal outcomes 
and alexithymic functioning [21,23,67-70].  
Current research on alexithymia has the potential for 
integrating findings over psychological and biological 
domains, which are often viewed as distinct entities [71-
75]. Several authors have addressed this dichotomy, so it 
would be fundamental to try to reach integrity overcoming 
theoretical oppositions. In addition to Damasio’s earlier 
studies [76,77], more recent contributions have taken up 
the issue [78-80], suggesting ways to reframe classical 
perspectives through objective methods and rigorous 
analyses.  
Conclusions 
The current study investigated the relationship between 
alexithymia, demographic variables, and specific health 
outcomes using validated instruments. Results indicated 
that alexithymia may play a role in a variety of health 
outcomes, including gastrointestinal problems, and 
decreased physical and energy status. Subsequent studies 
should expand the observation group and balance gender 
groups, as well as use research designs that enable stronger 
inferences regarding causal relationships.  
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